Impax Laboratories, Inc.
Records under this name other than the patents Impax Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
Showing 1 to 9 of 9 · Back to Impax Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,007,827 | Pharmaceutical Dosage Forms Having Immediate Release And/Or Controlled Release Properties Lapsed on the fee record Ended Aug 30, 2023 · Medium confidence | Lapsed on the fee record | Ended Aug 30, 2023 | Medium confidence |
| US 6,728,897 | Negotiating takeover in high availability cluster Formerly held Term ended Term ended Dec 26, 2021 · From the USPTO record | Term ended | Term ended Dec 26, 2021 | From the USPTO record |
| US 6,333,332 | Stabilized pharmaceutical compositions containing bupropion hydrochloride Term ended Term ended Aug 25, 2020 · From the USPTO record | Term ended | Term ended Aug 25, 2020 | From the USPTO record |
| US 6,602,521 | Multiplex drug delivery system suitable for oral administration Term ended Term ended Sep 29, 2018 · From the USPTO record | Term ended | Term ended Sep 29, 2018 | From the USPTO record |
| US 7,094,427 | Combination Immediate Release Controlled Release Levodopa/Carbidopa Dosage Forms Lapsed on the fee record Ended Aug 22, 2018 · High confidence | Lapsed on the fee record | Ended Aug 22, 2018 | High confidence |
| US 6,730,321 | Press Coated, Pulsatile Drug Delivery System Suitable for Oral Administration Term ended Ended no later than Jun 13, 2018 · Low confidence | Term ended | Ended no later than Jun 13, 2018 | Low confidence |
| US 6,372,254 | Press coated, pulsatile drug delivery system suitable for oral administration Term ended Term ended Apr 2, 2018 · From the USPTO record | Term ended | Term ended Apr 2, 2018 | From the USPTO record |
| US 6,531,158 | Drug delivery system for enhanced bioavailability of hydrophobic active ingredients Lapsed on the fee record Ended Mar 11, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 11, 2015 | From the USPTO record |
| US 5,885,616 | Sustained release drug delivery system suitable for oral administration Term ended Term ended no later than Mar 23, 2019 · Low confidence | Term ended | Term ended no later than Mar 23, 2019 | Low confidence |